FALCO is a parallel pragmatic randomized control trial addressing long-term effects of music therapy (MT) on substance use disorder (SUD).
600 participants will be recruited from multiple European countries (see Locations). They will be randomized into one of the following intervention arms: Active Music Group (AMG), Music Listening Group (MLG) or Treatment as Usual (TAU) as offered locally.
patients seeking or receiving treatment at the recruitment site for an existing substance use disorder based on ICD-10 criteria
≥18 years old
not currently undergoing detoxification (detoxification has been completed or is not currently planned at the time of recruitment)
any type of substance use including polysubstance and alcohol use
exclusively nicotine dependence
psychotic episode in the last 3 months
insufficient language skills to participate in treatment without the use of a translator
hearing impairment that considerably impairs hearing of music played at a moderate volume (not relevant if hearing is sufficiently compensated by a hearing aid)
NORCE Norwegian Research Centre AS
Lead sponsor
University of Bergen
Collaborator
Helse Stavanger HF
Collaborator
Sykehuset Innlandet HF
Collaborator
University of Vienna
Collaborator
Anton Proksch Institut
Collaborator
University of Music and Performing Arts, Vienna
Collaborator
Austrian Institute for Health Technology Assessment GmbH
Collaborator
Herzog College
Collaborator
Bar-Ilan University, Israel
Collaborator
University of Pavia
Collaborator
University of Gdańsk
Collaborator
Wojewódzki Ośrodek Terapii Uzależnień w Gdańsku
Collaborator
Institut d'Investigació Biomèdica de Bellvitge
Collaborator
Institució Catalana de Recerca i Estudis Avançats
Collaborator
Universitat de Girona
Collaborator
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Collaborator
Fundació Sanitària d'Igualada
Collaborator
University of Zurich
Collaborator